Have a feature idea you'd love to see implemented?
Let us know!
CVM Cel Sci Corp
Price (delayed)
$0.3992
Market cap
$29.58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.51
Enterprise value
$34.14M
CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in the Phase 3 study CEL-SCI treated patients
Highlights
Cel Sci's quick ratio has increased by 32% YoY
The company's EPS rose by 30% YoY and by 12% QoQ
The equity has soared by 52% from the previous quarter but it has decreased by 2.6% YoY
Key stats
What are the main financial stats of CVM
Market
Valuations
Earnings
Shares outstanding
74.11M
Market cap
$29.58M
Enterprise value
$34.14M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.91
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Net income
-$27.58M
EBIT
-$26.83M
EBITDA
-$22.86M
Free cash flow
-$18.91M
Per share
Balance sheet
Liquidity
EPS
-$0.51
EPS diluted
-$0.51
Free cash flow per share
-$0.35
Book value per share
$0.21
Revenue per share
$0
TBVPS
$0.5
Total assets
$26.99M
Total liabilities
$14.12M
Debt
$11.62M
Equity
$12.87M
Working capital
$1.44M
Debt to equity
0.9
Current ratio
1.31
Quick ratio
1.53
Net debt/EBITDA
-0.2
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-100.5%
Return on equity
-228.4%
Return on invested capital
-92.9%
Return on capital employed
-119.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CVM stock price
How has the Cel Sci stock price performed over time
Intraday
1.4%
1 week
-2.59%
1 month
-45.31%
1 year
-83.9%
YTD
-0.18%
QTD
-0.18%
Financial performance
How have Cel Sci's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$26.35M
Net income
-$27.58M
Gross margin
N/A
Net margin
N/A
Cel Sci's operating income has increased by 16% YoY and by 4.7% from the previous quarter
CVM's net income is up by 15% year-on-year and by 5% since the previous quarter
Growth
What is Cel Sci's growth rate over time
Valuation
What is Cel Sci stock price valuation
P/E
N/A
P/B
1.91
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 30% YoY and by 12% QoQ
The stock's price to book (P/B) is 82% less than its 5-year quarterly average of 10.7 and 75% less than its last 4 quarters average of 7.5
The equity has soared by 52% from the previous quarter but it has decreased by 2.6% YoY
Efficiency
How efficient is Cel Sci business performance
CVM's return on equity is down by 32% year-on-year but it is up by 4.6% since the previous quarter
The return on assets has declined by 13% year-on-year but it has grown by 2.1% since the previous quarter
Dividends
What is CVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CVM.
Financial health
How did Cel Sci financials performed over time
The total assets is 91% more than the total liabilities
Cel Sci's current ratio has soared by 105% from the previous quarter and by 6% YoY
Cel Sci's quick ratio has increased by 32% YoY
CVM's debt is 10% smaller than its equity
The equity has soared by 52% from the previous quarter but it has decreased by 2.6% YoY
The company's debt to equity fell by 37% QoQ and by 13% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.